MCE - Delayed Quote EUR

Laboratorio Reig Jofre, S.A. (RJF.MC)

Compare

2.9100

+0.0400

(+1.39%)

At close: November 1 at 5:35 PM GMT+1

Currency in EUR All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Total Revenue

331,642.0000

316,088.0000

271,150.0000

236,231.0000

230,079.0000

Cost of Revenue

142,612.0000

137,076.0000

113,807.0000

91,252.0000

89,682.0000

Gross Profit

189,030.0000

179,012.0000

157,343.0000

144,979.0000

140,397.0000

Operating Expense

174,787.0000

166,581.0000

148,135.0000

135,614.0000

130,539.0000

Operating Income

14,243.0000

12,431.0000

9,208.0000

9,365.0000

9,858.0000

Net Non Operating Interest Income Expense

-1,416.0000

-1,174.0000

-895.0000

-860.0000

-958.0000

Pretax Income

10,330.0000

10,496.0000

8,764.0000

5,793.0000

6,426.0000

Tax Provision

1,074.0000

1,099.0000

658.0000

713.0000

760.0000

Net Income Common Stockholders

9,266.0000

9,407.0000

8,107.0000

5,092.0000

5,672.0000

Diluted NI Available to Com Stockholders

9,266.0000

9,407.0000

8,107.0000

5,092.0000

5,672.0000

Basic EPS

0.12

0.10

0.07

Diluted EPS

0.12

0.10

0.07

Basic Average Shares

77,796.9030

78,804.0460

78,881.8540

77,854.0540

76,985.4450

Diluted Average Shares

77,796.9030

78,804.0460

78,881.8540

77,854.0540

76,985.4450

Total Operating Income as Reported

12,284.0000

10,510.0000

8,532.0000

8,863.0000

9,228.0000

Rent Expense Supplemental

916.0000

406.0000

711.0000

733.0000

Total Expenses

317,399.0000

303,657.0000

261,942.0000

226,866.0000

220,221.0000

Net Income from Continuing & Discontinued Operation

9,266.0000

9,407.0000

8,107.0000

5,092.0000

5,672.0000

Normalized Income

10,929.0335

11,034.6435

9,216.9042

7,230.8089

7,990.9511

Interest Income

174.0000

63.0000

101.0000

50.0000

32.0000

Interest Expense

1,098.0000

745.0000

687.0000

679.0000

680.0000

Net Interest Income

-1,416.0000

-1,174.0000

-895.0000

-860.0000

-958.0000

EBIT

11,428.0000

11,241.0000

9,451.0000

6,472.0000

7,106.0000

EBITDA

35,037.0000

34,386.0000

30,514.0000

24,519.0000

24,089.0000

Reconciled Cost of Revenue

142,612.0000

137,076.0000

113,807.0000

91,252.0000

89,682.0000

Reconciled Depreciation

23,609.0000

23,145.0000

21,063.0000

18,047.0000

16,983.0000

Net Income from Continuing Operation Net Minority Interest

9,266.0000

9,407.0000

8,107.0000

5,092.0000

5,672.0000

Total Unusual Items Excluding Goodwill

-1,856.0000

-1,818.0000

-1,200.0000

-2,439.0000

-2,630.0000

Total Unusual Items

-1,856.0000

-1,818.0000

-1,200.0000

-2,439.0000

-2,630.0000

Normalized EBITDA

36,893.0000

36,204.0000

31,714.0000

26,958.0000

26,719.0000

Tax Rate for Calcs

0.0001

Tax Effect of Unusual Items

-192.9665

-190.3565

-90.0958

-300.1911

-311.0489

12/31/2020 - 11/29/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

FAE.MC Faes Farma, S.A.

3.5800

+1.13%

0K9H.IL Faes Farma, S.A.

3.5575

+0.99%

ALM.MC Almirall, S.A.

9.11

+1.22%

HROW Harrow, Inc.

45.64

+1.29%

AKBA Akebia Therapeutics, Inc.

1.6900

+1.81%

TEVA Teva Pharmaceutical Industries Limited

18.45

+0.05%

TLRY Tilray Brands, Inc.

1.6400

0.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Laboratorio Reig Jofre, S.A. (RJF.MC)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers